Cytonics Corporation
12Patents
12Active
12Granted
48Portfolio score
Filing activity: Jun 1, 2007 → Mar 6, 2023 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9352021B2 | Systems, compositions, and methods for transplantation and treating conditions | Performing Operations; Transporting | 13 | Active |
| US7709215B2 | Method for diagnosing and treating acute joint injury | Physics | 10 | Active |
| US10265388B2 | Systems, compositions, and methods for transplantation | Chemistry; Metallurgy | 6 | Active |
| US10400028B2 | Therapeutic variant alpha-2-macroglobulin compositions | Physics | 4 | Active |
| US8338572B2 | Kits for biomarker detection and treatment selection | Physics | 2 | Active |
| US10940189B2 | Systems, compositions, and methods for transplantation | Chemistry; Metallurgy | 1 | Active |
| US8841079B2 | Fibronectin aggrecan biomarker for the identification of spinal and joint source of pain | Physics | 1 | Active |
| US11040092B2 | Systems, compositions, and methods for transplantation | Chemistry; Metallurgy | 1 | Active |
| US9498514B2 | Systems, compositions, and methods for transplantation and treating conditions | Performing Operations; Transporting | 1 | Active |
| US11634475B2 | Therapeutic variant alpha-2-macroglobulin compositions | Physics | 0 | Active |
| US10889631B2 | Therapeutic variant alpha-2-macroglobulin compositions | Physics | 0 | Active |
| US12195521B2 | Therapeutic variant alpha-2-macroglobulin compositions | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.